Skip to main content
. 2015 Jul 16;59(8):4997–4999. doi: 10.1128/AAC.01063-15

TABLE 1.

Whole-blood pharmacokinetic AUC and Cmax parameters of meropenem after subcutaneous administration of 300 mg/kg of body weight in combination with amoxicillin-clavulanate (s.c. at 200/50 mg/kg) in three different murine genetic backgroundsa

Mouse genetic background Cmax (μg/ml) AUC (μg · h/ml) T>MIC (h)b
TF3157 1.1 1.7 73, 36, 0
C57BL/6 0.03c 0.05c 0, 0, 0
TF 3157 DHP-I KO 6.6 8.8 66, 49, 39
a

All groups were pretreated with probenecid (orally [p.o.] at 200 mg/kg). s.c., subcutaneous.

b

Results shown are for MICs 1 to 3, which are 230 ng/mol, 625 ng/mol, and 1,250 ng/mol, respectively. The time over MIC (T>MIC) was calculated taking as a reference the simulated profile of the compound after 3-times-a-day administration for 8 days, and simulation was extended to 200 h.

c

The concentration measured was close to the threshold of detection. The wild-type and DHP-I KO mouse strains corresponded to a TF3157 genetic background.